Return On Equity of Atara Biotherapeutics, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Atara Biotherapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Atara Biotherapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -42%, a 131% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Return On Equity for 2024 was 86%, a 94% decline from 2023.
  • Atara Biotherapeutics, Inc. annual Return On Equity for 2023 was 1422%.
  • Atara Biotherapeutics, Inc. annual Return On Equity for 2022 was -115%, a 11% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Atara Biotherapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -42% -175% -131% 01 Jul 2025 30 Sep 2025
Q2 2025 -8.3% -210% -104% 01 Apr 2025 30 Jun 2025
Q1 2025 18% -369% -95% 01 Jan 2025 31 Mar 2025
Q4 2024 86% -1336% -94% 01 Oct 2024 31 Dec 2024
Q3 2024 134% +917% 01 Jul 2024 30 Sep 2024
Q2 2024 202% +517% 01 Apr 2024 30 Jun 2024
Q1 2024 387% +522% 01 Jan 2024 31 Mar 2024
Q4 2023 1422% +1537% 01 Oct 2023 31 Dec 2023
Q3 2023 -783% -679% -652% 01 Jul 2023 30 Sep 2023
Q2 2023 -315% -223% -241% 01 Apr 2023 30 Jun 2023
Q1 2023 -135% -13% -11% 01 Jan 2023 31 Mar 2023
Q4 2022 -115% -12% -11% 01 Oct 2022 31 Dec 2022
Q3 2022 -104% -17% -19% 01 Jul 2022 30 Sep 2022
Q2 2022 -92% -10% -12% 01 Apr 2022 30 Jun 2022
Q1 2022 -122% -44% -57% 01 Jan 2022 31 Mar 2022
Q4 2021 -103% -18% -22% 01 Oct 2021 31 Dec 2021
Q3 2021 -87% +7.7% +8.1% 01 Jul 2021 30 Sep 2021
Q2 2021 -82% +15% +15% 01 Apr 2021 30 Jun 2021
Q1 2021 -78% +31% +28% 01 Jan 2021 31 Mar 2021
Q4 2020 -85% +19% +18% 01 Oct 2020 31 Dec 2020
Q3 2020 -95% +4.6% +4.6% 01 Jul 2020 30 Sep 2020
Q2 2020 -97% -8.3% -9.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -109% -40% -58% 01 Jan 2020 31 Mar 2020
Q4 2019 -103% -47% -83% 01 Oct 2019 31 Dec 2019
Q3 2019 -100% -49% -97% 01 Jul 2019 30 Sep 2019
Q2 2019 -89% -39% -78% 01 Apr 2019 30 Jun 2019
Q1 2019 -69% -17% -33% 01 Jan 2019 31 Mar 2019
Q4 2018 -56% +0.55% +0.96% 01 Oct 2018 31 Dec 2018
Q3 2018 -51% -5.7% -13% 01 Jul 2018 30 Sep 2018
Q2 2018 -50% -10% -26% 01 Apr 2018 30 Jun 2018
Q1 2018 -52% -18% -54% 01 Jan 2018 31 Mar 2018
Q4 2017 -57% -29% -102% 01 Oct 2017 31 Dec 2017
Q3 2017 -45% -17% -61% 01 Jul 2017 30 Sep 2017
Q2 2017 -40% -17% -79% 01 Apr 2017 30 Jun 2017
Q1 2017 -34% -10% -44% 01 Jan 2017 31 Mar 2017
Q4 2016 -28% -4.5% -19% 01 Oct 2016 31 Dec 2016
Q3 2016 -28% -3.1% -13% 01 Jul 2016 30 Sep 2016
Q2 2016 -22% +19% +46% 01 Apr 2016 30 Jun 2016
Q1 2016 -23% 01 Jan 2016 31 Mar 2016
Q4 2015 -24% 01 Oct 2015 31 Dec 2015
Q3 2015 -25% 01 Jul 2015 30 Sep 2015
Q2 2015 -41% 01 Apr 2015 30 Jun 2015

Atara Biotherapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 86% -1336% -94% 01 Jan 2024 31 Dec 2024
2023 1422% +1537% 01 Jan 2023 31 Dec 2023
2022 -115% -12% -11% 01 Jan 2022 31 Dec 2022
2021 -103% -18% -22% 01 Jan 2021 31 Dec 2021
2020 -85% +19% +18% 01 Jan 2020 31 Dec 2020
2019 -103% -47% -83% 01 Jan 2019 31 Dec 2019
2018 -56% +0.55% +0.96% 01 Jan 2018 31 Dec 2018
2017 -57% -29% -102% 01 Jan 2017 31 Dec 2017
2016 -28% -4.5% -19% 01 Jan 2016 31 Dec 2016
2015 -24% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.